Nervgen Pharma NGEN
NASDAQ NGEN
$1.78 +0.02 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Price to Book (2024 - 2026)

Updated

Nervgen Pharma's (NGEN) Price to Book stood at 13.14 in the quarter ended Jun 30, 2026, down 82.3% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Price to Book (2024 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Nervgen Pharma's Price to Book came in at 179.24, up 120.0% from the prior year.

  • Across earlier years, Price to Book came in at 81.47 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Nervgen Pharma 140.18 Mn 140.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.14
Mar 31, 2026 74.31
Dec 31, 2025 178.90
Dec 31, 2024 83.13
API Access

Nervgen Pharma Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=NGEN&period=max&api_key=YOUR_API_KEY